Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit

Company to also share progress with cell-based virotherapy platforms for advanced solid tumors

...

Related Keywords

California ,United States ,Boston ,Massachusetts ,San Diego ,American ,Calidi Biotherapeutics ,Antoniof Santidrian Pharm ,Borisr Minev ,Antoniof Santidrian ,Jana Portnow ,Calidi Neuronova ,Oncolytic Virotherapy ,Oncolytic Virotherapies ,Scientific Affairs ,Northwestern University ,Scientific Affairs Of Calidi Biotherapeutics ,Calidi Biotherapeutics Inc ,Department Of Medical Oncology Therapeutics Research ,City Of Hope Comprehensive Cancer Center Presentation ,Company Registration ,City Of Hope Comprehensive Cancer Center ,University Of Chicago ,Medical Oncology ,Therapeutics Research ,Brain Tumor Program ,Hope Comprehensive Cancer Center ,Chief Scientific Officer ,Recurrent High Grade Glioma ,Dose Escalation Trial ,Newly Diagnosed ,Clinical Trial Initiation ,Advanced Solid Tumors ,Metastatic Solid ,Hope Comprehensive Cancer Center Presentation ,Optimized Cell Based Delivery ,Note Regarding Forward Looking ,Registration Statements ,Markets ,